Compare GATX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GATX | GRFS |
|---|---|---|
| Founded | 1898 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.8B |
| IPO Year | 1994 | N/A |
| Metric | GATX | GRFS |
|---|---|---|
| Price | $175.98 | $8.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $215.00 | $10.15 |
| AVG Volume (30 Days) | 177.4K | ★ 646.0K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | 1.51% | ★ 1.74% |
| EPS Growth | ★ 17.22 | N/A |
| EPS | ★ 9.12 | N/A |
| Revenue | ★ $1,740,400,000.00 | N/A |
| Revenue This Year | $42.09 | $5.33 |
| Revenue Next Year | $3.32 | $6.50 |
| P/E Ratio | $19.16 | ★ $18.67 |
| Revenue Growth | ★ 9.77 | N/A |
| 52 Week Low | $139.44 | $6.19 |
| 52 Week High | $199.00 | $11.14 |
| Indicator | GATX | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.00 | 30.37 |
| Support Level | $168.23 | $7.64 |
| Resistance Level | $176.55 | $9.11 |
| Average True Range (ATR) | 4.80 | 0.30 |
| MACD | -2.12 | -0.11 |
| Stochastic Oscillator | 3.54 | 4.38 |
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.